EnPlusOne Biosciences
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
313 Pleasant St Ste 4W, Watertown, Massa...Phone Number
(617) 744-6739Website
www.enplusonebio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About EnPlusOne Biosciences
Founded in 2022 and headquartered in Watertown, Massachusetts, EnPlusOne Biosciences is finding innovative solutions for emerging RNA therapeutics by harnessing the power and flexibility of enzymes to deliver RNA to the world.Explore more
EnPlusOne Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is EnPlusOne Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on EnPlusOne Biosciences recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at EnPlusOne Biosciences
Funding: Get notified immidiatlly once EnPlusOne Biosciences has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if EnPlusOne Biosciences has recently received funding, and reach out quickly before it becomes old news!
Check out if EnPlusOne Biosciences is spiking on competitors!
Click to see if EnPlusOne Biosciences had a recent Job posting/layoffs
EnPlusOne Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when EnPlusOne Biosciences launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to EnPlusOne Biosciences
Compare insights from companies similar to EnPlusOne Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
EnPlusOne Biosciences
<$5M
1-10
Private
$22M
2022
DA
Daniel AhlstedtCo-founder & Chief Operating Officer
Company Profile Activity
Activity Insights
EnPlusOne Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
EnPlusOne Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about EnPlusOne Biosciences.
EnPlusOne Biosciences financials insights
Gather financial insights about EnPlusOne Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$12M
2025
Other Financing Round
$10M
EnPlusOne Biosciences Tech Stack
A closer look at the technologies used by EnPlusOne Biosciences
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Event
Events
Event
Events
EnPlusOne Biosciences News & Media
EnPlusOne Biosciences To Present New Data at TIDES USA
WATERTOWN, Mass.--(BUSINESS WIRE)--EnPlusOne Biosciences, Inc., a biotechnology company pioneering enzymatic solutions for RNA manufacturing, will present new data from its proprietary ezRNA™ platform at TIDES USA, the leading conference focused on oligonucleotide and peptide therapeutics, taking place May 19-22 in San Diego at the Manchester Grand Hyatt. In a featured talk titled “Solving the Scale Problem: Template-independent Enzymatic Synthesis of siRNA Oligonucleotides,” EnPlusOne’s ChiefEnPlusOne Biosciences Appoints Clare Murray, Ph.D. as CEO
WATERTOWN, Mass.--(BUSINESS WIRE)--EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, today announced the appointment of Clare Murray, Ph.D., as Chief Executive Officer. Dr. Murray brings deep experience in corporate strategy and business development, having led multiple transactions with global pharmaceutical and innovative biotechnology companies. Her work forging strategic partnerships with CDMOs aligns directly with EnPlusOneEnPlusOne Biosciences Raises $10M in Financing
WATERTOWN, Mass.--(BUSINESS WIRE)--EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, today announced that it had raised additional funding to scale and drive continued technical advancements of its ezRNA™ synthesis platform. The round of financing, of approximately $10 million, was led by Northpond Ventures and Breakout Ventures, highlights their ongoing support and enthusiasm for the company’s progress. It is another key milest
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding EnPlusOne Biosciences
Sign Up For FreeTo access detailed company insights
Founded in 2022 and headquartered in Watertown, Massachusetts, EnPlusOne Biosciences is finding innovative solutions for emerging RNA therapeutics by harnessing the power and flexibility of enzymes to deliver RNA to the world.... Read More
